No Data
Key Deals This Week: Capri, WNS Holdings, Fintech Payoneer, Altus Power and More
PainReform Moves Towards Nasdaq Compliance With Strategic Acquisition
AI replacing animal experiments? A message from the FDA has left "monkey breeders" feeling devastated, and experts state that "we are still far from the stage of implementation."
① The news that the USA FDA has publicly stated it will gradually replace animal testing requirements has led to an increase in the stock prices of AI pharmaceutical companies, impacting traditional drug evaluation CRO companies; ② Some believe this action represents a trend in Industry development. However, others believe that it is far from being implementable.
PainReform Shareholders Approve Key Proposals at April Meeting
PainReform PRFX Market Expansion; Conduit CDT Share Repurchase
PainReform Acquires DeepSolar
